At Jubilant Organosys’s new $20m laboratory in a leafy suburb of Bangalore, Suriya Rao, a 29-year-old with a master’s degree in organic chemistry, hovers over flasks and burners, trying to initiate a reaction to create a molecule with medicinal properties.
In a room nearby, Delhi-born Rajiv Tyagi, a 33-year-old biologist, is cloning proteins to use in tests of newly synthesised molecules.
